Detrex Corporation

Detrex Corporation specializes in producing high-purity hydrochloric acid for diverse sectors such as pharmaceuticals, food and beverage, and semiconductors, ensuring compliance with strict quality standards and regulations. Founded in 1920, Detrex Corporation is based in Cleveland, US, and operates in the chemical manufacturing sector, focusing on hydrochloric acid. The company does not have any known subsidiaries or parent companies. Detrex has engaged in one significant deal, which occurred on November 10, 2017, with Italmatch Chemicals agreeing to acquire the company.

The acquisition was finalized in December 2017. Detrex Chemicals specializes in the production of high-purity hydrochloric acid tailored for various industries, including pharmaceuticals, food and beverage, semiconductors, and laboratory applications. Their core offerings include pharmaceutical-grade hydrochloric acid that meets stringent NF/EP/BP/JP/IP/ChP specifications, FDA-registered food-grade hydrochloric acid adhering to FSMA standards, and ultra-pure semiconductor-grade hydrochloric acid with trace levels as low as 1-100 parts per billion. The company's products are manufactured in the United States, ensuring compliance with CGMP regulations and catering to customers who prioritize quality and reliability in their chemical supply.

Detrex's clientele consists of pharmaceutical manufacturers, food processors, semiconductor companies, and laboratories across North America and select international markets, aiming to provide solutions that enhance product efficacy and safety. Detrex Chemicals operates on a business-to-business model, engaging with clients through direct sales and tailored partnerships. In the most recent year, the company generated revenue of USD 37. 50 mn through transactions involving bulk orders of hydrochloric acid and customized solutions to meet the unique needs of different industries.

Their flagship products include FDA-registered hydrochloric acid for pharmaceutical use and low trace element grades for semiconductor applications. Transactions typically involve long-term contracts or one-time purchases, providing flexibility for clients while ensuring a steady revenue stream for the company. Detrex Corporation plans for future growth include leveraging the recent acquisition by Italmatch Chemicals to expand its product line and enhance operational capabilities. The company aims to develop new formulations of hydrochloric acid tailored for emerging markets, particularly focused on the pharmaceutical and semiconductor industries.

The integration with Italmatch is expected to facilitate entry into new geographical regions, including Europe and Asia, by the end of 2018, enhancing their global footprint. The acquisition deal, completed in December 2017, is anticipated to support these strategic initiatives, allowing for increased investment in product development and market expansion.